Methotrexate Granules

(Product under development)
Methotrexate GranulesMethotrexate (rINN), abbreviated MTX and formerly known asamethopterin, is an antimetabolite and antifolate drug.

It is used in treatment of cancer,autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions.

It acts by inhibiting the metabolism of folic acid. Methotrexate began to replace the more toxic antifolate aminopterin starting in the 1950s. The drug was developed by Yellapragada Subbarao.

Available Form:
Methotrexate Granules
Methotrexate Pellets

Umang Pharmatech equipments used for production of Methotrexate Granules:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Methotrexate Granules
Systematic (IUPAC) Name
Methotrexate Granules
Methotrexate Granules
Chemical data
benzoyl)amino]pentanedioic acid
CAS number : 59-05-2
ATC code : L01BA01 L04AX03
PubChem : CID 126941
DrugBank : APRD00353
ChemSpider : 112728
KEGG : D00142
Formula : C20H22N8O5>
Mol. mass : 454.44 g/mol

* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech